Increasing the accessibility of long-acting reversible contraceptives through nurse-led insertions: A cost-benefit analysis

Reference

Botfield, J. R., Lacey, S., Fleming, K., McGeechan, K., & Bateson, D., 2020, Increasing the accessibility of long-acting reversible contraceptives through nurse-led insertions: A cost-benefit analysis, Collegian, 27(1) 109-114

Training midwives in the insertion of the contraceptive implant to increase uptake in the immediate postpartum period: a feasibility pilot study

Research status

In progress

Overview of Study

Australia has a relatively high rate of unintended pregnancy. Women may be particularly susceptible to unintended pregnancies in the 12 months after giving birth, partially due to difficulty accessing contraception. It is therefore essential that there be minimal barriers to accessing effective contraception in the postpartum period, including long-acting reversible contraceptives (LARC). LARC methods (including the implant and intrauterine devices) are the most effective at preventing unintended pregnancies.

Implanon NXT: Expert tips for best-practice insertion and removal

Reference

Pearson S, Stewart M, Bateson D, 2017, Implanon NXT: Expert tips for best-practice insertion and removal, Aust Fam Physician, 46(3) 104-108

Australian women's attitudes towards and understandings of the subdermal contraceptive implant: a qualitative study of never-users

Reference

Inoue K, Kelly M, Barratt A, Bateson D, Rutherford A, Black KI, Stewart M & Richters J, 2016, Australian women's attitudes towards and understandings of the subdermal contraceptive implant: a qualitative study of never-users, Journal of Family Planning and Reproductive Health Care, Online Online

A pilot study to assess the effect of three short-term treatments on frequent and/or prolonged bleeding compared to placebo in women using Implanon

Reference

Weisberg E, Hickey M, Palmer D, O'Connor V, Salamonsen LA, Findlay JK, Fraser IS, 2006, A pilot study to assess the effect of three short-term treatments on frequent and/or prolonged bleeding compared to placebo in women using Implanon, Human Reprod. 2006, 21(1) 295-302

Australian women's experience with Implanon

Reference

Weisberg E, Fraser I, 2005, Australian women's experience with Implanon, Aust Fam Physician, 34(8) 694-6

A detailed analysis of menstrual blood loss in women using Norplant and Nestorone progestogen-only contraceptive implants or vaginal rings

Reference

Fraser IS, Weisberg E, Minehan E, Johansson ED, 2000, A detailed analysis of menstrual blood loss in women using Norplant and Nestorone progestogen-only contraceptive implants or vaginal rings, Contraception, 61(4) 241-51

An initial pharmacokinetic study with a Metered Dose Transdermal System for delivery of the progestogen Nestorone as a possible future contraceptive

Reference

Fraser IS, Weisberg E, Kumar N, Kumar S, Humberstone AJ, McCrossin L, Shaw D, Tsong YY, Sitruk-Ware R, 2007, An initial pharmacokinetic study with a Metered Dose Transdermal System for delivery of the progestogen Nestorone as a possible future contraceptive, Contraception, 76(6) 432-8

A randomized controlled trial of treatment options for troublesome uterine bleeding in Implanon users.

Reference

E. Weisberg, M. Hickey, D. Palmer, V. O'Connor, L.A. Salamonsen, J.K. Findlay and I.S. Fraser, 2009, A randomized controlled trial of treatment options for troublesome uterine bleeding in Implanon users., Human Reproduction, 24(8) 1852-1861

Contraceptive efficacy and cycle control with the Ortho Evra/Evra transdermal system: the analysis of pooled data

Reference

Zieman M, Guillebaud J, Weisberg E, Shangold GA, Fisher AC, Creasy GW, 2002, Contraceptive efficacy and cycle control with the Ortho Evra/Evra transdermal system: the analysis of pooled data, Fertil Steril, 77(2 Suppl 2) S13-8